UniProt ID | ADRB2_HUMAN | |
---|---|---|
UniProt AC | P07550 | |
Protein Name | Beta-2 adrenergic receptor | |
Gene Name | ADRB2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 413 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . Early endosome . Colocalizes with VHL at the cell membrane (PubMed:19584355). Activated receptors are internalized into endosomes prior to their degradation in lysosomes (PubMed:20559325). |
|
Protein Description | Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine.. | |
Protein Sequence | MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | N-linked_Glycosylation | --MGQPGNGSAFLLA --CCCCCCCCEEEEC | 48.18 | UniProtKB CARBOHYD | |
15 | N-linked_Glycosylation | SAFLLAPNGSHAPDH CEEEECCCCCCCCCC | 60.02 | UniProtKB CARBOHYD | |
68 | Phosphorylation | FERLQTVTNYFITSL HHHHHHHHHHHHHHH | 27.82 | 17925438 | |
132 | Phosphorylation | CVIAVDRYFAITSPF HHHHHHCEEECCCCC | 7.90 | 17925438 | |
141 | Phosphorylation | AITSPFKYQSLLTKN ECCCCCCHHHHCCCC | 12.06 | 22817900 | |
143 | Phosphorylation | TSPFKYQSLLTKNKA CCCCCHHHHCCCCCH | 23.43 | 24719451 | |
146 | O-linked_Glycosylation | FKYQSLLTKNKARVI CCHHHHCCCCCHHHH | 37.55 | 31492838 | |
219 | Phosphorylation | LVIMVFVYSRVFQEA HHHHHHHHHHHHHHH | 4.55 | 17925438 | |
246 | Phosphorylation | RFHVQNLSQVEQDGR CEEECCHHHHCCCCC | 39.46 | 17525332 | |
261 | Phosphorylation | TGHGLRRSSKFCLKE CCCCCHHCCHHHHHH | 31.29 | 9461522 | |
262 | Phosphorylation | GHGLRRSSKFCLKEH CCCCHHCCHHHHHHH | 28.12 | 14722251 | |
263 | Ubiquitination | HGLRRSSKFCLKEHK CCCHHCCHHHHHHHH | 41.15 | - | |
265 | S-palmitoylation | LRRSSKFCLKEHKAL CHHCCHHHHHHHHHH | 6.45 | 27481942 | |
270 | Ubiquitination | KFCLKEHKALKTLGI HHHHHHHHHHHHHHH | 57.41 | - | |
308 | Phosphorylation | NLIRKEVYILLNWIG CCCHHHHHHHHHHHH | 6.22 | 67275799 | |
326 | Phosphorylation | SGFNPLIYCRSPDFR CCCCCEEEECCCHHH | 6.90 | 12436935 | |
341 | S-palmitoylation | IAFQELLCLRRSSLK HHHHHHHHHHHHHHH | 4.31 | 2540197 | |
345 | Phosphorylation | ELLCLRRSSLKAYGN HHHHHHHHHHHHHCC | 33.32 | 9461522 | |
346 | Phosphorylation | LLCLRRSSLKAYGNG HHHHHHHHHHHHCCC | 31.88 | 9461522 | |
348 | Ubiquitination | CLRRSSLKAYGNGYS HHHHHHHHHHCCCCC | 41.32 | - | |
350 | Phosphorylation | RRSSLKAYGNGYSSN HHHHHHHHCCCCCCC | 14.99 | 22817900 | |
354 | Phosphorylation | LKAYGNGYSSNGNTG HHHHCCCCCCCCCCC | 16.96 | 22817900 | |
355 | Phosphorylation | KAYGNGYSSNGNTGE HHHCCCCCCCCCCCC | 20.80 | 14722251 | |
356 | Phosphorylation | AYGNGYSSNGNTGEQ HHCCCCCCCCCCCCC | 40.03 | 14722251 | |
360 | Phosphorylation | GYSSNGNTGEQSGYH CCCCCCCCCCCCCCC | 43.42 | 18801735 | |
364 | Phosphorylation | NGNTGEQSGYHVEQE CCCCCCCCCCCCCHH | 36.70 | 11040066 | |
372 | Ubiquitination | GYHVEQEKENKLLCE CCCCCHHHHCCEECC | 67.30 | - | |
375 | Ubiquitination | VEQEKENKLLCEDLP CCHHHHCCEECCCCC | 43.88 | - | |
382 | Hydroxylation | KLLCEDLPGTEDFVG CEECCCCCCCCCCCC | 61.04 | 19584355 | |
384 | Phosphorylation | LCEDLPGTEDFVGHQ ECCCCCCCCCCCCCC | 30.37 | 18801735 | |
393 | Phosphorylation | DFVGHQGTVPSDNID CCCCCCCCCCCCCCC | 23.75 | 18801735 | |
395 | Hydroxylation | VGHQGTVPSDNIDSQ CCCCCCCCCCCCCCC | 35.48 | 19584355 | |
396 | Phosphorylation | GHQGTVPSDNIDSQG CCCCCCCCCCCCCCC | 38.66 | 18801735 | |
401 | Phosphorylation | VPSDNIDSQGRNCST CCCCCCCCCCCCCCC | 30.64 | 18801735 | |
407 | Phosphorylation | DSQGRNCSTNDSLL- CCCCCCCCCCCCCC- | 33.52 | 18801735 | |
408 | Phosphorylation | SQGRNCSTNDSLL-- CCCCCCCCCCCCC-- | 45.29 | 22275358 | |
411 | Phosphorylation | RNCSTNDSLL----- CCCCCCCCCC----- | 33.37 | 18801735 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
132 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PhosphoELM |
141 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PhosphoELM |
261 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
261 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
262 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
262 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
262 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
262 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
345 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
345 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
345 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
345 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
346 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
346 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
346 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
346 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
346 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
346 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
346 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
355 | S | Phosphorylation | Kinase | GRK2 | P21146 | PSP |
355 | S | Phosphorylation | Kinase | GRK-SUBFAMILY | - | GPS |
355 | S | Phosphorylation | Kinase | GRK_GROUP | - | PhosphoELM |
355 | S | Phosphorylation | Kinase | GRK6 | P43250 | PSP |
355 | S | Phosphorylation | Kinase | GRK2 | P25098 | PSP |
355 | S | Phosphorylation | Kinase | GRK3 | P35626 | PSP |
355 | S | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
355 | S | Phosphorylation | Kinase | GRK5 | P43249 | PSP |
356 | S | Phosphorylation | Kinase | GRK2 | P21146 | PSP |
356 | S | Phosphorylation | Kinase | GRK_GROUP | - | PhosphoELM |
356 | S | Phosphorylation | Kinase | GRK2 | P25098 | PSP |
356 | S | Phosphorylation | Kinase | GRK3 | P35626 | PSP |
356 | S | Phosphorylation | Kinase | GRK5 | P43249 | PSP |
356 | S | Phosphorylation | Kinase | GRK-SUBFAMILY | - | GPS |
356 | S | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
356 | S | Phosphorylation | Kinase | GRK6 | P43250 | PSP |
384 | T | Phosphorylation | Kinase | ARBK1 | P25098 | PhosphoELM |
384 | T | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
393 | T | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
396 | S | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
396 | S | Phosphorylation | Kinase | ARBK1 | P25098 | PhosphoELM |
401 | S | Phosphorylation | Kinase | ARBK1 | P25098 | PhosphoELM |
401 | S | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
407 | S | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
407 | S | Phosphorylation | Kinase | ARBK1 | P25098 | PhosphoELM |
411 | S | Phosphorylation | Kinase | GRK5 | P34947 | PSP |
411 | S | Phosphorylation | Kinase | GRK2 | P25098 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:18544533 |
- | K | Ubiquitination | E3 ubiquitin ligase | VHL | P40337 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ADRB2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00079 | Asthma | |||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
D00076 | Noradrenaline (JP16); Norepinephrine (INN); Nor adrenalin (TN) | |||||
D00095 | Adrenaline (JP16); Epinephrine (USP/INN); Adrenalin (TN); Auvi-q (TN); Epipen (TN) | |||||
D00124 | Ephedrine (USP); Ephedrine (TN) | |||||
D00255 | Carvedilol (JAN/USAN/INN); Artist (TN); Coreg (TN) | |||||
D00378 | Timolol (USAN); Timolol hemihydrate; Betimol (TN) | |||||
D00432 | Nadolol (JP16/USP/INN); Corgard (TN) | |||||
D00483 | Propranolol hydrochloride (JP16/USP); Inderal (TN); Innopran XL (TN) | |||||
D00485 | Pseudoephedrine hydrochloride (USP); Sudafed (TN) | |||||
D00513 | Pindolol (JP16/USP/INN); Blocklin-L (TN); Carvisken (TN); Visken (TN) | |||||
D00599 | Carteolol hydrochloride (JP16/USP); Cartrol (TN); Ocupress (TN) | |||||
D00600 | Labetalol hydrochloride (JP16/USP); Normodyne (TN); Trandate (TN) | |||||
D00602 | Penbutolol sulfate (JP16/USP); Levatol (TN) | |||||
D00603 | Timolol maleate (JP16/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) | |||||
D00683 | Salbutamol sulfate (JP16); Albuterol sulfate (USP); Accuneb (TN); Proventil (TN); Ventolin (TN) | |||||
D00684 | Bitolterol mesilate (JAN); Bitolterol mesylate (USAN); Tornalate (TN) | |||||
D00685 | Orciprenaline sulfate (JP16); Metaproterenol sulfate (USP); Alupent (TN) | |||||
D00686 | Pirbuterol acetate (USAN); Maxair (TN) | |||||
D00687 | Salmeterol xinafoate (JAN/USAN); Serevent (TN) | |||||
D00688 | Terbutaline sulfate (JP16/USP); Brethine (TN) | |||||
D00996 | Epinephrine hydrochloride (JAN); Adrenalin chloride (TN) | |||||
D01017 | Dipivefrin hydrochloride (JAN/USP); Propine (TN) | |||||
D01025 | Levobunolol hydrochloride (JAN/USP); Betagan (TN) | |||||
D01026 | Sotalol hydrochloride (JAN/USP); Betapace (TN); Sorine (TN) | |||||
D01182 | Alprenolol hydrochloride (JP16/USAN); Regletin (TN) | |||||
D01263 | Ritodrine hydrochloride (JP16/USP); Yutopar (TN) | |||||
D01349 | Pirbuterol hydrochloride (JAN/USAN) | |||||
D01360 | Clenbuterol hydrochloride (JAN/USP); Spiropent (TN) | |||||
D01362 | Tulobuterol hydrochloride (JP16); Hokunalin (TN); Respacal (TN) | |||||
D01373 | Formoterol fumarate (USAN); Foradil (TN) | |||||
D01386 | Ephedrine hydrochloride (JP16/USP); Ephedrine hydrochloride (TN) | |||||
D01390 | dl-Isoprenaline hydrochloride (JAN); Isoproterenol hydrochloride (USP); Isuprel (TN); Proternol-S (T | |||||
D01428 | Fenoterol hydrobromide (JAN); Berotec (TN) | |||||
D01444 | Bunitrolol hydrochloride (JAN); Betrilol (TN) | |||||
D01454 | Bupranolol hydrochloride (JP16) | |||||
D01469 | Amosulalol hydrochloride (JP16); Lowgan (TN) | |||||
D01504 | Bufetolol hydrochloride (JP16); Adobiol (TN) | |||||
D01512 | Befunolol hydrochloride (JAN); Bentos (TN) | |||||
D01543 | Nylidrin hydrochloride (JAN); Buphenine hydrochloride; Arlidin (TN) | |||||
D01589 | Mabuterol hydrochloride (JAN); Broncholin (TN) | |||||
D01635 | Methoxyphenamine hydrochloride (JAN); Phenamine (TN) | |||||
D01691 | Nipradilol (JAN/INN); Hypadil (TN) | |||||
D01748 | Isoxsuprine hydrochloride (JP16/USP); Duvadilan (TN) | |||||
D01794 | Bopindolol malonate (JAN); Sandonorm (TN) | |||||
D01795 | Tilisolol hydrochloride (JAN); Selecal (TN) | |||||
D01806 | Oxprenolol hydrochloride (JP16/USP); Okuspurecol (TN) | |||||
D01830 | Arotinolol hydrochloride (JP16); Almarl (TN) | |||||
D01835 | Clorprenaline hydrochloride (JAN/USAN) | |||||
D01952 | L-Methylephedrine hydrochloride (JAN) | |||||
D01958 | Indenolol hydrochloride (JP16) | |||||
D01978 | Trimetoquinol hydrochloride; Tretoquinol; Inolin (TN) | |||||
D02066 | Isoprenaline sulfate (JAN); Isoproterenol sulfate (USP); Luf-Iso (TN); Medihaler-Iso (TN) | |||||
D02081 | Metipranolol hydrochloride; Optipranolol (TN) | |||||
D02093 | Isoetharine hydrochloride (USP); BETA-2 (TN) | |||||
D02109 | dl-Methylephedrine hydrochloride (JP16); Methy-F (TN) | |||||
D02147 | Albuterol (USP); Salbutamol; Proventil (TN) | |||||
D02149 | Epinephrine bitartrate (JAN/USP); Asmatane mist (TN); Medihaler-epi (TN) | |||||
D02150 | l-Isoprenaline hydrochloride (JP16); Proternol-L (TN) | |||||
D02151 | Tulobuterol (JAN/INN); Atenos (TN); Hokunalin (TN) | |||||
D02281 | Levalbuterol hydrochloride (USAN); Xopenex (TN) | |||||
D02349 | Dipivefrin (USAN); Dipivefrine (INN) | |||||
D02359 | Ritodrine (USAN/INN) | |||||
D02374 | Metipranolol (USAN/INN) | |||||
D02389 | Primidolol (USAN/INN) | |||||
D02396 | Hexoprenaline sulfate (USAN); Delaprem (TN) | |||||
D02404 | Procaterol hydrochloride (USAN); Pro-Air (TN) | |||||
D02702 | Talibegron hydrochloride (USAN) | |||||
D02765 | Adaprolol maleate (USAN) | |||||
D02834 | Alprenoxime hydrochloride (USAN) | |||||
D02976 | Arbutamine hydrochloride (USAN); Genesa (TN) | |||||
D02981 | Arformoterol tartrate (USAN); Brovana (TN) | |||||
D03170 | Bucindolol hydrochloride (USAN) | |||||
D03177 | Bunolol hydrochloride (USAN) | |||||
D03198 | Butoxamine hydrochloride (USAN) | |||||
D03402 | Carbuterol hydrochloride (USAN) | |||||
D03415 | Carvedilol phosphate hydrate (JAN); Carvedilol phosphate (USAN); Coreg CR (TN) | |||||
D03449 | Cetamolol hydrochloride (USAN) | |||||
D03490 | Cicloprolol hydrochloride (USAN) | |||||
D03502 | Cimaterol (USAN/INN) | |||||
D03587 | Colterol mesylate (USAN) | |||||
D03729 | Dexpropranolol hydrochloride (USAN) | |||||
D03759 | Diacetolol hydrochloride (USAN) | |||||
D03891 | Dopexamine (USAN/INN) | |||||
D04018 | Ephedrine sulfate (USP); Isofedrol (TN) | |||||
D04157 | Fenoterol (USAN/INN) | |||||
D04190 | Flestolol sulfate (USAN) | |||||
D04625 | Isoetharine (USP); Isoetarine (INN) | |||||
D04626 | Isoetharine mesylate (USP); Bronkometer (TN) | |||||
D04701 | Levalbuterol sulfate (USAN) | |||||
D04703 | Levalbuterol tartrate (USAN); Xopenex HFA (TN) | |||||
D04888 | Medroxalol (USAN/INN) | |||||
D04889 | Medroxalol hydrochloride (USAN) | |||||
D04954 | Metaproterenol polistirex (USAN) | |||||
D05037 | Trimetoquinol hydrochloride hydrate (JP16); Tretoquinol hydrate; Caluyon (TN) | |||||
D05206 | Norepinephrine bitartrate (USP); Levophed (TN) | |||||
D05277 | Formoterol fumarate hydrate (JP16); Formoterol fumarate dihydrate; Atock (TN); Foradil (TN) | |||||
D05345 | Pamatolol sulfate (USAN) | |||||
D05366 | Procaterol hydrochloride hydrate (JP16); Meptin (TN) | |||||
D05476 | Picumeterol fumarate (USAN) | |||||
D05648 | Pseudoephedrine polistirex (USAN); Pseudo-12 (TN) | |||||
D05649 | Pseudoephedrine sulfate (USP); Afrinol (TN) | |||||
D05691 | Ractopamine hydrochloride (USAN) | |||||
D05718 | Reproterol hydrochloride (USAN) | |||||
D05730 | Rimiterol hydrobromide (USAN) | |||||
D05792 | Salmeterol (USAN/INN) | |||||
D05832 | Sibenadet hydrochloride (USAN); Viozan (TN) | |||||
D05902 | Soterenol hydrochloride (USAN) | |||||
D06374 | Zinterol hydrochloride (USAN) | |||||
D07156 | Alprenolol (INN) | |||||
D07181 | Mepindolol (INN) | |||||
D07182 | Tertatolol (INN) | |||||
D07183 | Cloranolol (INN) | |||||
D07377 | Bambuterol (INN) | |||||
D07451 | Amosulalol (INN) | |||||
D07463 | Arformoterol (INN) | |||||
D07465 | Arotinolol (INN) | |||||
D07489 | Bambuterol hydrochloride; Bambec (TN) | |||||
D07534 | Bitolterol (INN) | |||||
D07537 | Bopindolol (INN); Sandonorm (TN) | |||||
D07551 | Buphenine (INN) | |||||
D07590 | Bupranolol (INN) | |||||
D07608 | Carazolol (INN); Conducton (TN); Suacron [veterinary] (TN) | |||||
D07624 | Carteolol (INN) | |||||
D07713 | Clenbuterol (INN); Contraspasmin (TN); Planipart [veterinary] (TN) | |||||
D07990 | Formoterol (INN); Oxis (TN) | |||||
D08039 | Hexoprenaline (INN); Ipradol (TN) | |||||
D08074 | Penbutolol (INN) | |||||
D08078 | Indenolol (INN) | |||||
D08090 | Isoprenaline (INN) | |||||
D08092 | Isoxsuprine (INN); Dilator (TN) | |||||
D08093 | Isoxsuprine lactate; Duphaspasmin [veterinary] (TN) | |||||
D08106 | Labetalol (INN) | |||||
D08115 | Levobunolol (INN) | |||||
D08124 | Levosalbutamol (INN) | |||||
D08206 | Methylephedrine (BAN) | |||||
D08284 | Norepinephrine hydrochoride; (-)-Noradrenaline hydrochloride; Arterenol (TN) | |||||
D08300 | Orciprenaline (INN); Metaproterenol | |||||
D08318 | Oxprenolol (INN); Oxprenolol (TN) | |||||
D08387 | Pirbuterol (INN) | |||||
D08424 | Procaterol (INN); Meptin (TN) | |||||
D08443 | Propranolol (INN); Propranolol (TN) | |||||
D08449 | Pseudoephedrine (INN); Neodurasina (TN); Acunaso (TN) | |||||
D08474 | Reproterol (INN) | |||||
D08525 | Sotalol (INN); Darob mite (TN) | |||||
D08570 | Terbutaline (INN); Asthmasian (TN) | |||||
D08572 | Tertatolol hydrochloride; Artex (TN) | |||||
D08598 | Tilisolol (INN) | |||||
D08600 | Timolol (INN); Timolol (TN); Betimol (TN) | |||||
D08629 | Tretoquinol (INN) | |||||
D08945 | Milveterol hydrochloride (USAN) | |||||
D09318 | Indacaterol (USAN/INN) | |||||
D09319 | Indacaterol maleate (JAN/USAN); Arcapta neohaler (TN) | |||||
D09696 | Vilanterol (USAN) | |||||
D09697 | Vilanterol trifenatate (JAN/USAN) | |||||
D09794 | Norepinephrine hydrochloride (JAN); (+/-)-Noradrenaline hydrochloride | |||||
D09842 | dl-Methylephedrine saccharinate (JAN) | |||||
D09843 | Beradilol monoethyl maleate (JAN); TZC-5665 | |||||
D10020 | Olodaterol hydrochloride (JAN/USAN) | |||||
D10145 | Olodaterol (USAN/INN) | |||||
D10219 | abediterol (USAN/INN) | |||||
D10220 | Abediterol napadisylate (USAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Hydroxylation | |
Reference | PubMed |
"Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3and ubiquitylation by pVHL."; Xie L., Xiao K., Whalen E.J., Forrester M.T., Freeman R.S., Fong G.,Gygi S.P., Lefkowitz R.J., Stamler J.S.; Sci. Signal. 2:RA33-RA33(2009). Cited for: INTERACTION WITH EGLN3 AND VHL, SUBCELLULAR LOCATION, INDUCTION,UBIQUITINATION, HYDROXYLATION AT PRO-382 AND PRO-395, AND MASSSPECTROMETRY. | |
Palmitoylation | |
Reference | PubMed |
"The palmitoylation state of the beta(2)-adrenergic receptor regulatesthe synergistic action of cyclic AMP-dependent protein kinase andbeta-adrenergic receptor kinase involved in its phosphorylation anddesensitization."; Moffett S., Rousseau G., Lagace M., Bouvier M.; J. Neurochem. 76:269-279(2001). Cited for: EFFECT OF PALMITOYLATION, PHOSPHORYLATION AT SER-345 AND SER-346, ANDMUTAGENESIS OF 345-SER-SER-346. | |
"Palmitoylation of the human beta 2-adrenergic receptor. Mutation ofCys341 in the carboxyl tail leads to an uncoupled nonpalmitoylatedform of the receptor."; O'Dowd B.F., Hnatowich M., Caron M.G., Lefkowitz R.J., Bouvier M.; J. Biol. Chem. 264:7564-7569(1989). Cited for: PALMITOYLATION AT CYS-341, AND MUTAGENESIS OF CYS-341. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-246, AND MASSSPECTROMETRY. | |
"The palmitoylation state of the beta(2)-adrenergic receptor regulatesthe synergistic action of cyclic AMP-dependent protein kinase andbeta-adrenergic receptor kinase involved in its phosphorylation anddesensitization."; Moffett S., Rousseau G., Lagace M., Bouvier M.; J. Neurochem. 76:269-279(2001). Cited for: EFFECT OF PALMITOYLATION, PHOSPHORYLATION AT SER-345 AND SER-346, ANDMUTAGENESIS OF 345-SER-SER-346. | |
"Mutation of tyrosine-141 inhibits insulin-promoted tyrosinephosphorylation and increased responsiveness of the human beta 2-adrenergic receptor."; Valiquette M., Parent S., Loisel T.P., Bouvier M.; EMBO J. 14:5542-5549(1995). Cited for: MUTAGENESIS OF TYR-141; TYR-350; TYR-354 AND TYR-366, ANDPHOSPHORYLATION AT TYR-141. |